nach oben

Erschienen in:

25.10.2019 | Typ-2-Diabetes | Leitthema

Langzeitfolgen und Präventionsstrategien für Frauen nach Gestationsdiabetes

verfasst von: Dr. rer. nat. Louise Fritsche, Julia Hummel, M. Sc., Prof. Dr. med. Martin Heni, Prof. Dr. med. Andreas Fritsche

Erschienen in: Die Diabetologie | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hintergrund

Frauen, die in einer Schwangerschaft einen Gestationsdiabetes mellitus (GDM) hatten, haben ein deutlich erhöhtes Risiko der Entwicklung eines Diabetes mellitus Typ 2, kardiovaskulärer Krankheiten, einer Depression post partum und weiterer Erkrankungen.

Umfang der Übersichtsarbeit

Im vorliegenden Beitrag sind Studien zusammengefasst, in denen die Langzeitfolgen eines Gestationsdiabetes untersucht und die Höhe des Risikos ermittelt wurden. Außerdem wird die aktuelle Studienlage im Hinblick auf die optimale Präventionsstrategie für diese Hochrisikopatientinnen beleuchtet.

Schlussfolgerung

Die Langzeitfolgen eines GDM sind nicht nur auf Störungen des Glukosestoffwechsels begrenzt, sondern beinhalten auch ein hohes Risiko für kardiovaskuläre Erkrankungen, kognitive und psychiatrische Komplikationen und Tumorerkrankungen. Geeignete Präventionsstrategien sind v. a. die Lebensstilinterventionsprogramme, aber auch die medikamentöse Prävention erwies sich in methodisch gut geführten Studien als erfolgreich.

Ajala O, Jensen LA, Ryan E, Chik C (2015) Women with a history of gestational diabetes on long-term follow up have normal vascular function despite more dysglycemia, dyslipidemia and adiposity. Diabetes Res Clin Pract 110:309–314. https://doi.org/10.1016/j.diabres.2015.10.004 CrossRefPubMed

Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. Circulation 120:1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644 CrossRefPubMed

Arafa A, Dong J‑Y (2019) Gestational diabetes and risk of postpartum depressive symptoms: a meta-analysis of cohort studies. J Affect Disord 253:312–316. https://doi.org/10.1016/j.jad.2019.05.001 CrossRefPubMed

Aroda VR, Christophi CA, Edelstein SL et al (2015) The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up. J Clin Endocrinol Metab 100:1646–1653. https://doi.org/10.1210/jc.2014-3761 CrossRefPubMedPubMedCentral

Azami M, Badfar G, Soleymani A, Rahmati S (2019) The association between gestational diabetes and postpartum depression: a systematic review and meta-analysis. Diabetes Res Clin Pract 149:147–155. https://doi.org/10.1016/j.diabres.2019.01.034 CrossRefPubMed

Azen SP, Peters RK, Berkowitz K et al (1998) TRIPOD (TRoglitazone in the prevention of diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin Trials 19:217–231. https://doi.org/10.1016/S0197-2456(97)00151-7 CrossRefPubMed

Bærug A, Sletner L, Laake P et al (2018) Recent gestational diabetes was associated with mothers stopping predominant breastfeeding earlier in a multi-ethnic population. Acta Paediatr 107:1028–1035. https://doi.org/10.1111/apa.14274 CrossRefPubMed

Beharier O, Shoham-Vardi I, Pariente G et al (2015) Gestational diabetes mellitus is a significant risk factor for long-term maternal renal disease. J Clin Endocrinol Metab 100:1412–1416. https://doi.org/10.1210/jc.2014-4474 CrossRefPubMed

Bellamy L, Casas J‑P, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779. https://doi.org/10.1016/S0140-6736(09)60731-5 CrossRefPubMed

10.

Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of Pancreatic β‑Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women. Diabetes 51:2796–2803. https://doi.org/10.2337/diabetes.51.9.2796 CrossRefPubMed

11.

Burlina S, Dalfrà MG, Chilelli NC, Lapolla A (2016) Gestational diabetes mellitus and future cardiovascular risk: an update. Int J Endocrinol. https://doi.org/10.1155/2016/2070926 CrossRefPubMedPubMedCentral

12.

Butte NF, King JC (2005) Energy requirements during pregnancy and lactation. Public Health Nutr 8:1010–1027. https://doi.org/10.1079/PHN2005793 CrossRefPubMed

13.

Chireh B, Li M, D’Arcy C (2019) Diabetes increases the risk of depression: a systematic review, meta-analysis and estimates of population attributable fractions based on prospective studies. Prev Med Rep 14:100822. https://doi.org/10.1016/j.pmedr.2019.100822 CrossRefPubMedPubMedCentral

14.

Chodick G, Elchalal U, Sella T et al (2010) The risk of overt diabetes mellitus among women with gestational diabetes: a population-based study. Diabet Med 27:779–785. https://doi.org/10.1111/j.1464-5491.2010.02995.x CrossRefPubMed

15.

Clark CE, Rasgon NL, Reed DE, Robakis TK (2019) Depression precedes, but does not follow, gestational diabetes. Acta Psychiatr Scand 139:311–321. https://doi.org/10.1111/acps.12998 CrossRefPubMed

16.

Clark HD, Graham ID, Karovitch A, Keely EJ (2009) Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 200:634.e1–634.e7. https://doi.org/10.1016/j.ajog.2009.01.003 CrossRef

17.

Cust AE, Kaaks R, Friedenreich C et al (2007) Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 92:255–263. https://doi.org/10.1210/jc.2006-1371 CrossRefPubMed

18.

Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445. https://doi.org/10.1016/S0140-6736(96)90013-6 CrossRefPubMed

19.

Di Benedetto A, Russo GT, Corrado F et al (2005) Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Invest 28:34–38. https://doi.org/10.1007/BF03345527 CrossRefPubMed

20.

Fallon A, Dunne F (2015) Breastfeeding practices that support women with diabetes to breastfeed. Diabetes Res Clin Pract 110:10–17. https://doi.org/10.1016/j.diabres.2015.07.006 CrossRefPubMed

21.

Feig DS, Zinman B, Wang X, Hux MDJE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. Can Med Assoc J 179:229–234. https://doi.org/10.1503/cmaj.080012 CrossRef

22.

Ferrara A, Hedderson MM, Albright CL et al (2011) A pregnancy and postpartum lifestyle intervention in women with gestational diabetes mellitus reduces diabetes risk factors: a feasibility randomized control trial. Diabetes Care 34:1519–1525. https://doi.org/10.2337/dc10-2221 CrossRefPubMedPubMedCentral

23.

Ferrara A, Hedderson MM, Brown SD et al (2016) The comparative effectiveness of diabetes prevention strategies to reduce postpartum weight retention in women with gestational diabetes mellitus: the gestational diabetes’ effects on moms (GEM) cluster randomized controlled trial. Diabetes Care 39:65–74. https://doi.org/10.2337/dc15-1254 CrossRefPubMed

24.

Friedman S, Rabinerson D, Bar J et al (1995) Microalbuminuria following gestational diabetes. Acta Obstet Gynecol Scand 74:356–360. https://doi.org/10.3109/00016349509024428 CrossRefPubMed

25.

Fritsche L, Sarief M, Wagner R et al (2018) Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits. Diabetes Res Clin Pract 146:251–257. https://doi.org/10.1016/j.diabres.2018.11.003 CrossRefPubMed

26.

Giner V, Tormos C, Chaves FJ et al (2004) Microalbuminuria and oxidative stress in essential hypertension. J Intern Med 255:588–594. https://doi.org/10.1046/j.1365-2796.2003.01280.x CrossRefPubMed

27.

Goueslard K, Cottenet J, Mariet A‑S et al (2016) Early cardiovascular events in women with a history of gestational diabetes mellitus. Cardiovasc Diabetol 15:15. https://doi.org/10.1186/s12933-016-0338-0 CrossRefPubMedPubMedCentral

28.

Gunderson EP, Kim C, Quesenberry CP et al (2014) Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort. Metabolism 63:941–950. https://doi.org/10.1016/j.metabol.2014.04.006 CrossRefPubMedPubMedCentral

29.

Guo J, Chen J‑L, Whittemore R, Whitaker E (2016) Postpartum lifestyle interventions to prevent type 2 diabetes among women with history of gestational diabetes: a systematic review of randomized clinical trials. J Womens Health 25:38–49. https://doi.org/10.1089/jwh.2015.5262 CrossRef

30.

Hakkarainen H, Huopio H, Cederberg H et al (2016) The risk of metabolic syndrome in women with previous GDM in a long-term follow-up. Gynecol Endocrinol 32:920–925. https://doi.org/10.1080/09513590.2016.1198764 CrossRefPubMed

31.

Heitritter SM, Solomon CG, Mitchell GF et al (2005) Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90:3983–3988. https://doi.org/10.1210/jc.2004-2494 CrossRefPubMed

32.

Hui AL, Sevenhuysen G, Harvey D, Salamon E (2014) Stress and anxiety in women with gestational diabetes during dietary management. Diabetes Educ 40:668–677. https://doi.org/10.1177/0145721714535991 CrossRefPubMed

33.

Hummel S, Beyerlein A, Pfirrmann M et al (2018) Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: a phase II, randomized, double-blind, placebo-controlled study. Mol Metab 9:168–175. https://doi.org/10.1016/j.molmet.2017.12.015 CrossRefPubMedPubMedCentral

34.

John CM, Yusof MNIS, Aziz ASH, Mohd Fauzi F (2018) Maternal cognitive impairment associated with gestational diabetes mellitus—a review of potential contributing mechanisms. Int J Mol Sci. https://doi.org/10.3390/ijms19123894 CrossRefPubMedPubMedCentral

35.

Keskin FE, Ozyazar M, Pala AS et al (2015) Evaluation of cognitive functions in gestational diabetes mellitus. Exp Clin Endocrinol Diabetes 123:246–251. https://doi.org/10.1055/s-0034-1395634 CrossRefPubMed

36.

Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868. https://doi.org/10.2337/diacare.25.10.1862 CrossRefPubMed

37.

Kistorp C (2005) N‑terminal pro-brain natriuretic peptide, C‑reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293:1609. https://doi.org/10.1001/jama.293.13.1609 CrossRefPubMed

38.

Kjos SL, Peters RK, Xiang A et al (1995) Predicting future diabetes in latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 44:586–591. https://doi.org/10.2337/diab.44.5.586 CrossRefPubMed

39.

Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403. https://doi.org/10.1056/NEJMoa012512 CrossRefPubMed

40.

Kramer CK, Campbell S, Retnakaran R (2019) Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 62:905–914. https://doi.org/10.1007/s00125-019-4840-2 CrossRefPubMed

41.

Lauenborg J, Mathiesen E, Hansen T et al (2005) The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 90:4004–4010. https://doi.org/10.1210/jc.2004-1713 CrossRefPubMed

42.

Lee AJ, Hiscock RJ, Wein P et al (2007) Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30:878–883. https://doi.org/10.2337/dc06-1816 CrossRefPubMed

43.

Lekva T, Michelsen AE, Aukrust P et al (2017) Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus. Cardiovasc Diabetol 16:5. https://doi.org/10.1186/s12933-016-0492-4 CrossRefPubMedPubMedCentral

44.

Lekva T, Michelsen AE, Bollerslev J et al (2016) Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study. Cardiovasc Diabetol 15:23. https://doi.org/10.1186/s12933-016-0345-1 CrossRefPubMedPubMedCentral

45.

Maggino T, Pirrone F, Velluti F, Bucciante G (1993) The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias. Eur J Gynaecol Oncol 14:119–126PubMed

46.

Mautner E, Greimel E, Trutnovsky G et al (2009) Quality of life outcomes in pregnancy and postpartum complicated by hypertensive disorders, gestational diabetes, and preterm birth. J Psychosom Obstet Gynecol 30:231–237. https://doi.org/10.3109/01674820903254757 CrossRef

47.

McCloskey L, Sherman ML, John SM et al (2019) Navigating a “perfect storm” on the path to prevention of type 2 diabetes mellitus after gestational diabetes: lessons from patient and provider narratives. Matern Child Health J 23:603–612. https://doi.org/10.1007/s10995-018-2649-0 CrossRefPubMed

48.

Meltzer-Brody S (2011) New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum. Dialogues Clin Neurosci 13:89–100PubMedPubMedCentral

49.

Moulton CD, Pickup JC, Ismail K (2015) The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol 3:461–471. https://doi.org/10.1016/S2213-8587(15)00134-5 CrossRefPubMed

50.

Much D, Beyerlein A, Roßbauer M et al (2014) Beneficial effects of breastfeeding in women with gestational diabetes mellitus. Mol Metab 3:284–292. https://doi.org/10.1016/j.molmet.2014.01.002 CrossRefPubMedPubMedCentral

51.

Nagamani M, Stuart CA (1998) Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 179:6–12. https://doi.org/10.1016/s0002-9378(98)70244-3 CrossRefPubMed

52.

Nicklas JM, Zera CA, England LJ et al (2014) A web-based lifestyle intervention for women with recent gestational diabetes mellitus: a randomized controlled trial. Obstet Gynecol 124:563–570. https://doi.org/10.1097/AOG.0000000000000420 CrossRefPubMedPubMedCentral

53.

Noctor E, Crowe C, Carmody LA et al (2015) ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol 52:153–160. https://doi.org/10.1007/s00592-014-0621-z CrossRefPubMed

54.

Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97. https://doi.org/10.1038/nri2921 CrossRefPubMedPubMedCentral

55.

Park Y‑MM, O’Brien KM, Zhao S et al (2017) Gestational diabetes mellitus may be associated with increased risk of breast cancer. Br J Cancer 116:960–963. https://doi.org/10.1038/bjc.2017.34 CrossRefPubMedPubMedCentral

56.

Pelimanni E, Jehkonen M (2019) Type 2 diabetes and cognitive functions in middle age: a meta-analysis. J Int Neuropsychol Soc 25:215–229. https://doi.org/10.1017/S1355617718001042 CrossRef

57.

Peng Y‑S, Lin J‑R, Cheng B‑H et al (2019) Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan. BMJ Open 9:e24583. https://doi.org/10.1136/bmjopen-2018-024583 CrossRefPubMedPubMedCentral

58.

Pérez-Ferre N, Del Valle L, Torrejón MJ et al (2015) Diabetes mellitus and abnormal glucose tolerance development after gestational diabetes: A three-year, prospective, randomized, clinical-based, Mediterranean lifestyle interventional study with parallel groups. Clin Nutr 34:579–585. https://doi.org/10.1016/j.clnu.2014.09.005 CrossRefPubMed

59.

Perrin M, Terry M, Kleinhaus K et al (2007) Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study. BMC Med 5:25. https://doi.org/10.1186/1741-7015-5-25 CrossRefPubMedPubMedCentral

60.

Potzel A, Fritsche A, Fritsche L et al (2019) Prävention des Typ-2-Diabetes nach Schwangerschaftsdiabetes. Diabetes Aktuell 17:98–100. https://doi.org/10.1055/a-0873-5594 CrossRef

61.

Powe CE, Tobias DK, Michels KB et al (2017) History of gestational diabetes mellitus and risk of incident invasive breast cancer among parous women in the nurses’ health study II prospective cohort. Cancer Epidemiol Biomarkers Prev 26:321–327. https://doi.org/10.1158/1055-9965.EPI-16-0601 CrossRefPubMed

62.

Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93:4774–4779. https://doi.org/10.1210/jc.2008-0772 CrossRefPubMedPubMedCentral

63.

Rawal S, Olsen SF, Grunnet LG et al (2018) Gestational diabetes mellitus and renal function: a prospective study with 9‑ to 16-year follow-up after pregnancy. Diabetes Care 41:1378–1384. https://doi.org/10.2337/dc17-2629 CrossRefPubMedPubMedCentral

64.

Retnakaran R, Qi Y, Connelly PW et al (2010) Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 95:670–677. https://doi.org/10.1210/jc.2009-1990 CrossRefPubMed

65.

Rossetti L, Massillon D, Barzilai N et al (1997) Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 272:27758–27763. https://doi.org/10.1074/jbc.272.44.27758 CrossRefPubMed

66.

Ruohomäki A, Toffol E, Upadhyaya S et al (2018) The association between gestational diabetes mellitus and postpartum depressive symptomatology: A prospective cohort study. J Affect Disord 241:263–268. https://doi.org/10.1016/j.jad.2018.08.070 CrossRefPubMed

67.

Russo IH, Russo J (2011) Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 16:221–233. https://doi.org/10.1007/s10911-011-9228-y CrossRefPubMed

68.

Saucedo R, Valencia J, Gutierrez C, Zarate A (2017) The role of Leptin in gestational diabetes mellitus. In: Leptin Prod. Regul. Funct, S 131–150

69.

Saucedo R, Valencia J, Peña-Cano MI et al (2018) Breastfeeding and gestational diabetes. Gestation Diabetes. https://doi.org/10.5772/intechopen.82000 CrossRef

70.

Schäfer-Graf U, Laubner K, Hummel S et al (2018) Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. Diabetol Stoffwechs 13:S174–S184. https://doi.org/10.1055/a-0598-3468 CrossRef

71.

Schwartz N, Nachum Z, Green MS (2015) The prevalence of gestational diabetes mellitus recurrence—effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol 213:310–317. https://doi.org/10.1016/j.ajog.2015.03.011 CrossRefPubMed

72.

Shankar A, Sun L, Klein BEK et al (2011) Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 80:1231–1238. https://doi.org/10.1038/ki.2011.283 CrossRefPubMedPubMedCentral

73.

Shen Y, Li W, Leng J et al (2019) High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes. Diabetes Res Clin Pract 150:219–226. https://doi.org/10.1016/j.diabres.2019.03.030 CrossRefPubMed

74.

Thadhani R, Wolf M, Hsu-Blatman K et al (2003) First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am J Obstet Gynecol 189:171–176. https://doi.org/10.1067/mob.2003.343 CrossRefPubMed

75.

Tong G‑X, Cheng J, Chai J et al (2014) Association between gestational diabetes mellitus and subsequent risk of cancer: a systematic review of epidemiological studies. Asian Pac J Cancer Prev 15:4265–4269. https://doi.org/10.7314/apjcp.2014.15.10.4265 CrossRefPubMed

76.

Tovar A, Chasan-Taber L, Eggleston E, Oken E (2011) Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis 8(6):A124PubMedPubMedCentral

77.

Victora CG, Bahl R, Barros AJD et al (2016) Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387:475–490. https://doi.org/10.1016/S0140-6736(15)01024-7 CrossRefPubMed

78.

Wartko PD, Beck TL, Reed SD et al (2017) Association of endometrial hyperplasia and cancer with a history of gestational diabetes. Cancer Causes Control 28:819–828. https://doi.org/10.1007/s10552-017-0908-9 CrossRefPubMed

79.

Wójcik M, Chmielewska-Kassassir M, Grzywnowicz K et al (2014) The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM). Endokrynol Pol 65:134–142. https://doi.org/10.5603/EP.2014.0019 CrossRefPubMed

80.

Wolf M, Sauk J, Shah A et al (2004) Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 27:21–27. https://doi.org/10.2337/diacare.27.1.21 CrossRefPubMed

81.

Xiang AH, Peters RK, Kjos SL et al (2006) Effect of pioglitazone on pancreatic β‑cell function and diabetes risk in hispanic women with prior gestational. Diabetes Diabetes 55:517–522. https://doi.org/10.2337/diabetes.55.02.06.db05-1066 CrossRefPubMed

82.

Xie C, Wang W, Li X et al (2019) Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature. J Matern Fetal Neonatal Med 32:1022–1032. https://doi.org/10.1080/14767058.2017.1397117 CrossRefPubMed

83.

Xu J, Zhao YH, Chen YP et al (2014) Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. ScientificWorldJournal. https://doi.org/10.1155/2014/926932 CrossRefPubMedPubMedCentral

84.

Xu Y, Shen S, Sun L et al (2014) Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis. Plos One 9:e87863. https://doi.org/10.1371/journal.pone.0087863 CrossRefPubMedPubMedCentral

Titel: Langzeitfolgen und Präventionsstrategien für Frauen nach Gestationsdiabetes
verfasst von: Dr. rer. nat. Louise Fritsche
Julia Hummel, M. Sc.
Prof. Dr. med. Martin Heni
Prof. Dr. med. Andreas Fritsche
Publikationsdatum: 25.10.2019
Verlag: Springer Medizin
Schlagwörter: Typ-2-Diabetes
Gestationsdiabetes
Affektive Störungen
Affektive Störungen
Gestationsdiabetes
Glukosebelastungstest
Lebensstilinterventionen
Erschienen in: Die Diabetologie / Ausgabe 8/2019
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI: https://doi.org/10.1007/s11428-019-00544-3

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.

Zu den Praxisempfehlungen

Passend zum Thema

Alarmierender Anstieg psychischer Erkrankungen bei jungen Patienten

Der neue DAK-Psychreport 2024 zeigt, dass psychische Erkrankungen wie z. B. Depressionen insbesondere in der Altersgruppe der 25–29-jährigen Männer deutlich angestiegen sind. [1] Was gibt es in dieser Altersgruppe im Hinblick auf Diagnostik und Therapie einer Depression besonders zu beachten?

Photosensibilisierung durch Medikamente: So schützen Sie Ihre Patienten

Nicht alle Patient*innen können den Sommer unbeschwert genießen. Bestimmte Medikamente können bei ihnen unter UV-Strahlung phototoxische Reaktionen auslösen. Hier erfahren Sie, wie Sie Ihre Patienten schützen können.

Depression behandeln. Natürlich.

Hier erhalten Sie Updates zum aktuellen Stand der Wissenschaft bei der Therapie von Depressionen. Insbesondere sind dort detaillierte Erklärungen zum Wirkmechanismus von hochdosiertem Johanniskraut-Extrakt zu finden. Schauen Sie vorbei!

Springer Medizin

Zusammenfassung

Hintergrund

Umfang der Übersichtsarbeit

Schlussfolgerung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

Aktuell geltende Leitlinie Gestationsdiabetes

Magazin

Kontinuierliche Glukosemessung bei Diabetes mellitus Typ 1

CME: Interventionen am diabetischen Herzen

Immunsignatur und Krankheitsprogression bei Typ‑1‑Diabetes

Konservative und medikamentöse Therapie des Gestationsdiabetes mellitus

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Passend zum Thema

Alarmierender Anstieg psychischer Erkrankungen bei jungen Patienten

Photosensibilisierung durch Medikamente: So schützen Sie Ihre Patienten

Depression behandeln. Natürlich.